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Abstract 
 
Anxiety disorders are among the most common emotional difficulties experienced by children 
and young people. They cause significant disturbance to the lives of young people and their 
families and present a risk for lifelong psychological disturbance. Effective psychological (i.e. 
Cognitive Behaviour Therapy (CBT)) and pharmacological interventions (e.g. selective serotonin 
reuptake inhibitors (SSRIs)) have been established. However the risk of adverse effects and 
unknown long term effects of using SSRIs has led to recommendations that CBT is delivered as 
a first line intervention. Recent innovations have included the development of low intensity CBT 
programmes, delivered briefly via parents or online. These hold promise to increase access to 
psychological therapies for children and young people with these common and severe 
difficulties. 
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Introduction 
Anxiety disorders are among the most common mental health difficulties across the lifespan, 
with a lifetime prevalence of 28.8%. 
1
 They commonly have their onset during childhood or 
adolescence, with approximately 50% of those affected in adulthood first experiencing 
difficulties before the age of 11 years.
1
 Indeed the prevalence of anxiety disorders in childhood 
and adolescence is high, with worldwide prevalence rates estimated at 6.5%.
2
 This high 
prevalence is of serious concern given that childhood anxiety disorders often run a chronic 
course, are associated with substantial interference in young peoples’ social, educational and 
family lives, and are a risk for the development of other mental health problems in later life, such 
as depression.
3-5
 Effective psychological and pharmacological interventions for childhood 
anxiety disorders have been established, and early treatment has been found to be associated with 
lasting benefits, including reduced suicide ideation in adulthood.
6 
However, relatively few 
children and adolescents in need access these treatments
7
, and of those that do, a significant 
minority do not benefit.
8
.  This paper will give an overview of recent developments in the 
treatment of anxiety disorders in children and young people, with a particular focus on how to 
increase the number of children affected by these common difficulties who are able to access and 
benefit from evidence-based interventions. The pertinent literature was identified using PubMed 
and Google Scholar until March 31
st
 2015 and the reference lists of identified reports. 
 
What do anxiety disorders look like in children and adolescents? 
Anxiety is a normal emotion that everyone experiences at times. The content of normative fears, 
anxieties, and worries in childhood typically follows a developmental course, characterized by 
early fears relating to separation from a caregiver to more complex concerns, such as being 
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negatively socially evaluated during adolescence.
9 10
 As can be seen in Table 1, the onset of 
particular types of anxiety disorders often mirrors the normative development of these sorts of 
fears and worries, with, for example, separation anxiety disorder typically having a relatively 
early onset and social anxiety disorder having a later onset. Furthermore, the sorts of fears and 
worries that children and young people with an anxiety disorder experience may not differ 
substantially in content from the normative fears and worries of their peers.
11
 Instead an anxiety 
disorder is distinguished from the usual fears and worries that children and young people 
experience based on (i) the frequency that the fears/worries occur, (ii) the interference caused 
(for example, due to avoidance , distress, and/or associated physical symptoms), and (iii) the 
duration of the problem.
12
 The most common anxiety disorders experienced by children and 
young people in both clinic and community populations are separation anxiety disorder, social 
anxiety disorder, generalized anxiety disorder, and specific phobias.
13 14 
 However, young people 
may also experience the remaining DSM-5 anxiety disorders of selective mutism, panic disorder 
and agoraphobia, either on their own or alongside other anxiety disorders. A summary of the 
clinical characteristics for each of the DSM-5 anxiety disorders are given in Table 1. 
 
What treatments are effective for anxiety disorders in children and adolescents? 
(i) Psychological Interventions 
Cognitive Behaviour Therapy (CBT) has been far more extensively evaluated than any other 
intervention for anxiety disorders in children and adolescents. CBT for anxiety disorders 
focusses on identifying and challenging thoughts and behaviours that contribute to the 
maintenance of a disorder, counteracting avoidance through exposure to the feared situations or 
objects, and developing alternative responses that break the maintaining cycle.
15
 The most recent 
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Cochrane review of CBT for childhood anxiety disorders identified 41 studies 
8
 with young 
people aged 4-18 years (although those under the age of 7 years were relatively under-
represented). The majority of studies used a generic treatment approach rather than being 
designed for treatment of a specific anxiety disorder. Based on the 26 studies included in the 
analyses, 59.4% of those who received CBT remitted from their anxiety disorder compared to 
17.5% of the waitlist controls, as defined by absence of an anxiety disorder, as diagnosed by a 
reliable and valid structured interview. The Number Needed to Treat (NNT) was 3, meaning that 
for one additional participant to attain remission, three participants would have needed to receive 
treatment. Notably there was a moderate degree of inconsistency between study findings, but this 
was not accounted for by the delivery format of CBT, i.e. group, individual, or family formats. 
Only three studies looked at the comparative remission rates of CBT versus a waitlist control 
beyond the post-treatment assessment. Overall 77% of those who received CBT and 52% of 
those in the waitlist conditions no longer had an anxiety disorder at the long-term follow-up (6 – 
24 months), which fell short of significance (and the same was true for symptom reduction). In 
the three studies compared longer-term remission in CBT to an active control (e.g. 
psychoeducation and support), remission rates were 60% and 42% respectively which did not 
reflect a significant difference (and again the same was true on the basis of symptom reduction). 
However the ‘active treatment control’ did include a CBT programme delivered in a low 
intensity form (e.g. brief parent-led CBT approaches, see below). To date no trials have 
compared CBT to a non-CBT based active treatment condition that is actually used within 
therapeutic contexts (with most trials using control interventions that simply control for spending 
time talking to a therapist), so we have no evidence on which to conclude that CBT is more 
effective than another psychological therapy that might be used in child and adolescent mental 
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health settings. In the absence of robust evidence that any other psychological treatment 
approach is effective, CBT remains the first choice treatment approach.  
 
While CBT has been established as being better than no treatment, a significant minority of 
children (approximately 40%) continue to experience significant disturbance at the end of a 
course of treatment.  One of the major challenges now is to establish who CBT does and does not 
work for and to identify what is required in order to improve outcomes. Although recent reviews 
of studies that have examined predictors of treatment outcome for children and adolescents with 
anxiety disorders have concluded that there is no clear and consistent pattern in terms of 
demographic and clinical factors that are associated with treatment outcomes (e.g. Knight, 
McLellan, Jones, & Hudson, 2014)
16
, the majority of studies included in these reviews have been 
vastly underpowered. A recent collaboration, the Genes for Treatment (GxT) Study, has 
addressed this problem by collating CBT treatment outcome data from a number of sites 
internationally. Participants were 1,519 children (aged 5-18 years, although the majority were 
pre-adolescent) who had a primary anxiety disorder. The most consistent finding was that 
individuals with social anxiety disorder, comorbid mood or externalising disorders had poorer 
outcomes both immediately after CBT and at longer term follow-up.
17
 Ongoing work is now 
required to establish how to improve treatment outcomes in these contexts. 
 
While the GxT study failed to find a significant independent association between parental 
anxiety, depression and stress symptoms and child/adolescent CBT outcomes, significant 
associations have typically been found where studies have examined the presence of parental 
anxiety disorder status (at least in pre-adolescent children), with roughly half as many children 
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recovering following CBT where one or more of their parents also has an anxiety disorder (e.g. 
Bodden et al., 2008
18
; Hudson et al., 2013).
 19
 This is of potential importance, given the high 
degree to which anxiety disorders run in families (e.g. Cooper et al., 2006).
20
 However, in a 
recent trial of 210 families in which both the child (aged 7-12 years) and their mother met 
diagnostic criteria for a current anxiety disorder, we found relatively good outcomes (with 60-
75% recovered by the 12 month follow-up) for children following CBT regardless of the nature 
of parental support (which included treatment of the mother’s anxiety disorder, an intervention 
focused on mother-child interactions, or active control conditions).
21
  Of particular note, 
improvements in maternal mental health were found across all treatment conditions, highlighting 
the reciprocal nature of child and parental anxiety. In other words, children with anxiety 
disorders can achieve good outcomes in the context of parental anxiety disorders and these 
positive effects are likely to generalize to bring benefits to the wider family. 
 
(ii) Pharmacological and combined interventions 
The most recent Cochrane review of the efficacy of pharmacotherapy for anxiety disorders in 
children and young people identified 22 trials of short-term selective serotonin/norepinephrine 
reuptake inhibitors (SSRI/SNRI) administration, of which 14 studies included ‘treatment 
response’ as an outcome.22 Pharmacotherapy was found to be effective (58% responders) 
compared to placebo (31.5% responders; NNT = 4). There was significant variation in trial 
outcomes, however this was not accounted for by the type of medication (SSRI/SNRI). Of note, 
the majority of included studies focused on paediatric Obsessive Compulsive Disorder (OCD) 
which is no longer categorized as an ‘anxiety disorder’ in the widely used diagnostic manual, the 
DSM-5 (DSM-5 reference- APA)- leaving few studies to inform practice about the common 
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anxiety disorders which are the focus of this paper.  However, a significant development in this 
field is the Child/Adolescent Anxiety Multimodal Study (CAMS) which assigned 488 children 
(aged 7-17 years) with a primary diagnosis of separation anxiety disorder, generalized anxiety 
disorder, or social anxiety disorder to (a) 14 sessions of CBT, (b) sertraline (up to 200 mg per 
day), (c) a combination of CBT and sertraline, or (d) a placebo drug for 12 weeks. All therapies 
were superior to placebo in terms of treatment response, with 80.7% ‘much/very much 
improved’ for the combination treatment, 59.7% for CBT, and 54.9% for sertraline.23  
 
As the largest single trial conducted within this field, CAMS has presented opportunities to 
explore questions that individual studies have previously been underpowered to address, in 
particular relating to who does and does not benefit from intervention.  In CAMS, and partially 
consistent with the GxT findings reported above, poorer outcomes were found (across all 
treatment conditions) for those with higher initial anxiety severity, adolescents (versus children), 
participants of minority status, those with higher levels of caregiver strain and those with social 
anxiety disorder (although these associations varied somewhat depending on the study outcome 
used).
24, 25
 Few factors were associated with differential responses between treatment conditions, 
although there was some suggestion that the participant’s principal diagnosis may moderate 
outcomes- with individuals with separation anxiety disorder appearing to respond best to the 
combination treatment, those with social anxiety disorder responding best to either of the 
condition that included sertraline, and those with GAD responding best to either condition that 
included CBT.
25 
These secondary analyses should be considered as preliminary, however may 
offer some interesting directions for future research, and, ultimately practice. 
 
9 
 
A recent analysis of adverse events in CAMS concluded that sertraline was generally tolerable 
and safe as an acute treatment, however there was an increased rate of psychiatric adverse events 
(specifically disinhibition and increased motor activity) in the treatment groups containing 
sertraline compared to CBT (reported in 15.7% of the CBT + sertraline group, 7.5% of the 
sertraline group and 2.1% of the CBT group).
 26 
Although the figure for the CBT group is 
extremely low, it still serves to remind us that any treatment has the potential to cause negative 
effects and harm; however, this is an area that has been under-researched in studies of 
psychological therapy for children and young people to date. When children (7-12 years) and 
adolescents (13-17 years) were compared, children in the sertraline arm showed more adverse 
events overall than the adolescents. Notably, the majority of participants in this study were 
children, with only 25.6% of participants aged 13 years or older, so caution is needed in drawing 
conclusions and recommendations for the adolescent group. Furthermore there remains limited 
evidence related to the optimum dosage of SSRIs, their long-term positive and/or adverse effects, 
and the effects of treatment discontinuation. On the basis of their findings, the authors  highlight 
‘the need for careful assessment and monitoring of adverse events’ (Rynn et al., 2015; p 186) 
with SSRI treatments for children and adolescents with anxiety disorders, and suggest that ‘it 
may be prudent, especially for children less than 12 years of age, to consider treatment with CBT 
first’ (p186). This suggestion is consistent with the recent NICE guideline for social anxiety 
disorder 
27 
which include specific guidelines relating to children and young people. It 
recommends that affected children and young people should be offered individual or group CBT 
focused on social anxiety disorder using routine sessional outcome measures to monitor 
progress, and that pharmacological approaches should not ‘routinely’ be offered (NICE 
guideline). There is an absence of data on the treatment preferences of children and young people 
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with anxiety disorders, however parents of anxious children, prefer CBT to pharmacological 
interventions for their children, believing it to be more acceptable, believable, and effective in 
the short- and long-term.
 28
 In line with the NICE recommendations and parental preferences, the 
remainder of this review will focus predominantly on CBT approaches to the treatment of 
anxiety disorders in children and adolescents. 
 
How can we increase access to evidence-based interventions for children and young people 
with anxiety disorders? 
Studies in various countries, including the UK, USA and Australia, have identified that only a 
minority of children experiencing emotional or behavioural problems access professional support 
(e.g. Green et al., 2005
29
; Sawyer et al., 2001
30
) and this problem appears to be particularly acute 
for anxiety disorders. 
31 7 
One reason for the lack of access to evidence based treatments is no 
doubt that CBT is costly to deliver. For example, the U.K. Improving Access to Psychological 
Treatments Children and Young People’s initiative (CYP-IAPT) recommends the ‘Coping Cat’ 
programme
32 
which involves 16 weekly 50 minute sessions. Furthermore CBT involves 
specialist training and supervision for therapists which only a minority (about 20%) of 
professionals in UK child and adolescent mental health services (CAMHS) have received
33 
with 
two-thirds of CAMHS professionals reporting that they lack key CBT skills. 
 
In line with guidance for increasing access to treatment in adult populations (e.g., NICE, 2011), 
recent therapeutic innovations have focused on brief or low-intensity versions of CBT that can be 
delivered by non-specialists, with the ultimate aim of delivering treatment within a stepped-care 
framework. The logic here is to deliver brief, relatively simple, first-line treatments routinely to 
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service users with a relatively good prognosis, reserving more intensive treatments for those who 
do not respond to the first-line treatment and those whose prognostic profile indicates that they 
require more input (e.g., Bower & Gilbody, 2005).
34
 In recent years 'low intensity' approaches to 
the treatment of childhood anxiety disorders have been developed and evaluated, in particular (a) 
brief interventions in which parents are guided by a therapist in the application of a book to help 
their child overcome their difficulties with anxiety, and (b) interventions that are predominantly 
delivered electronically (i.e. online or similar) with therapist support.  
 
(a) Brief parent-led guided CBT for child anxiety disorders 
In this approach parents are provided with written resources that guide them in how to help their 
child apply CBT principles within their day to day life, and typically a therapist supports the 
parent in putting these principles in to place with their child. This approach has been evaluated 
predominantly with pre-adolescent children and found to be effective in Australian rural and 
urban populations 
35-37
 and recently in a UK CAMHS population.
38
 Typically these studies have 
found outcomes that are similar to those found in trials of more intensive CBT (e.g. 76% 
‘much/very much improved’ following only 5.5 hours of therapist support, compared with 25% 
in the waitlist condition; NNT= 2).
38
 Notably this approach has been found to be effective even 
when delivered by non-specialists
38
 and feasible within UK and US primary care services
39 40 
suggesting that this may be a cost-effective means to improve access to evidence based 
treatments for children with anxiety disorders. 
 
(b) E-therapies 
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Over the last five years there has been enormous growth in the use and popularity of ‘e-
therapies’, no doubt due to the rapid rate of adoption of technology in to peoples’ everyday lives, 
and the potential that this approach brings to deliver interventions efficiently. Despite this growth 
and enthusiasm there remains a lack of robust evaluation of e-therapies for anxiety disorders in 
children and adolescents, although some promising findings have emerged. A recent systematic 
review identified seven CBT-based programs that have been systematically evaluated with 
children or adolescents with mixed anxiety disorders, mixed anxiety and depression, or social 
anxiety disorder specifically.
41
 In all cases, the programs were supported with therapist input, but 
to varying extents. Overall, anxiety improved, with medium effect sizes, however there was less 
data for children than for adolescents and the data with children was considered to be weaker. 
Taken together, these studies suggest that e-therapies may be a promising low-intensity approach 
for the treatment of anxiety disorders in children and, perhaps particularly, adolescents. 
 
Implications for clinical practice 
The substantial societal burden associated with anxiety disorders in childhood and adolescence 
highlights the need for effective identification and intervention. Effective psychological and 
pharmacological interventions do exist, yet psychological interventions can be difficult to access 
and pharmacological interventions bring greater risk of adverse effects and may be less popular.  
As such, there is a need for services to develop stepped care models of treatment in which low 
intensity treatments are delivered as a first step, with more intensive treatments reserved for 
those who do not or who are unlikely to benefit from the low intensity approach (see Figure 1). 
Indeed, a number of studies have now demonstrated the feasibility and effectiveness of low 
intensity approaches, in particular brief parent-led guided CBT for children with anxiety 
13 
 
disorders, and online CBT for adolescents with anxiety disorders. As an example, the UK 
Improving Access to Psychological Therapies (IAPT) programme has embedded a stepped care 
model in to adult mental health services, with low intensity psychological interventions now 
readily available in many regions of the UK and a rapid uplift in the number of adults with 
common mental health disorders who have accessed evidence based psychological therapies (e.g. 
Department of Health, 2012).
 42
 A similar model of service delivery is now required for children 
and adolescents with common mental health disorders, such as anxiety disorders, where effective 
low intensity interventions exist in order to help many children and young people overcome 
problems before they become so severe as to require specialist, high intensity interventions.  
14 
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Table 1. The characteristics and age of onset for DSM-5 anxiety disorders. 
 
  Age of onset (in years)ᵃ 
Anxiety disorder Clinical characteristics Median Inter-quartile range 
Separation anxiety 
disorder 
Developmentally inappropriate and excessive fear/anxiety 
concerning separation from those to whom the child is attached, 
which has been present for at least 4 weeks. 
7 6-10 
Specific phobia Marked fear/anxiety about a specific object or situation that is out 
of proportion to the actual danger posed and the sociocultural 
context and is persistent, typically lasting 6 months or more. The 
object or situation almost always provokes immediate fear/anxiety 
and is actively avoided or endured with intense fear/anxiety.  
7 5-12 
Selective mutism Consistent failure to speak in specific social situations in which 
there is an expectation for speaking despite speaking in other 
situations, for at least 1 month (not limited to the first month of 
school). 
- - 
21 
 
Social anxiety 
disorder 
Marked fear/anxiety about one or more social situations in which 
the individual is exposed to possible scrutiny by others, occurring 
in peer settings and not just in interactions with adults. Situations 
are avoided or endured with intense fear/anxiety and the 
fear/anxiety is out of proportion to the actual threat posed and 
sociocultural context, typically lasting for 6 months or more. 
13 8-15 
Agoraphobia  Marked fear/anxiety about 2 or more of the following situations: 
using public transport, being in open or enclosed spaces, standing 
in line or being in a crowd or being outside of the home alone. The 
situations almost always provoke fear/anxiety due to thoughts that 
escape might be difficult, help might not be available or other 
incapacitating/embarrassing symptoms and situations are actively 
avoided, require the presence of a companion or are endured with 
intense fear/anxiety, lasting 6 months or more. 
20 13-33 
Panic disorder Recurrent unexpected panic attacks, consisting of an abrupt surge 
of intense fear/discomfort that peaks within minutes and includes 4 
24 16-40 
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symptoms such as palpitations, sweating, trembling, sensations of 
shortness of breath, chest pain, nausea, dizziness). At least 1 attack 
has been followed by at least 1 month of persistent worry about 
additional attacks or their consequences, or a significant 
maladaptive change in behaviour related to the attacks. 
Generalized 
anxiety disorder 
Excessive anxiety and worry that is difficult to control, associated 
with at least one physical symptom (e.g., restlessness, difficulty 
concentrating, sleep disturbance), occurs more days than not for at 
least 6 months. 
31 20-47 
Note. ᵃ Reported in Kessler et al. (2005). The inter-quartile range is the number of years between the 25th and 75th percentiles of the 
age-of-onset distributions. All anxiety disorders (except panic disorder) require that the disturbance causes clinically significant 
distress or impairment in areas such as academic or social functioning. 
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